188 related articles for article (PubMed ID: 2476269)
1. In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I and pokeweed mitogen: the contribution of CD5+ (Leu 1) B cells.
Karsh J; Goldstein R; Lazarovits AI
Clin Exp Immunol; 1989 Aug; 77(2):179-83. PubMed ID: 2476269
[TBL] [Abstract][Full Text] [Related]
2. In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I: evidence for the role of Leu-2-positive T suppressor cells and radiosensitive T helper cells.
Goldstein R; Perelmutter L; Karsh J
Clin Exp Immunol; 1987 Aug; 69(2):358-67. PubMed ID: 2958196
[TBL] [Abstract][Full Text] [Related]
3. In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis.
Nonaka S; Yasuda M; Nobunaga M
J Rheumatol; 1993 Sep; 20(9):1478-84. PubMed ID: 7513025
[TBL] [Abstract][Full Text] [Related]
4. Frequency analysis of human peripheral blood B cells producing IgM-rheumatoid factor. Differential effects of stimulation with monoclonal antibodies to CD3 and Staphylococcus aureus.
Hirohata S; Inoue T; Miyamoto T
J Immunol; 1990 Sep; 145(6):1681-6. PubMed ID: 2144005
[TBL] [Abstract][Full Text] [Related]
5. Bacterial peptidoglycan induces in vitro rheumatoid factor production by lymphocytes of healthy subjects.
Levy RJ; Haidar M; Park H; Tar L; Levinson AI
Clin Exp Immunol; 1986 May; 64(2):311-7. PubMed ID: 3488857
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus Cowan I. Potent stimulus of immunoglobulin M rheumatoid factor production.
Levinson AI; Tar L; Carafa C; Haidar M
J Clin Invest; 1986 Sep; 78(3):612-7. PubMed ID: 3489006
[TBL] [Abstract][Full Text] [Related]
7. Prominent IgM rheumatoid factor production by human cord blood lymphocytes stimulated in vitro with Staphylococcus aureus Cowan I.
Levinson AI; Dalal NF; Haidar M; Tar L; Orlow M
J Immunol; 1987 Oct; 139(7):2237-41. PubMed ID: 3655363
[TBL] [Abstract][Full Text] [Related]
8. Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens.
Zupo S; Dono M; Azzoni L; Chiorazzi N; Ferrarini M
Eur J Immunol; 1991 Feb; 21(2):351-9. PubMed ID: 1705511
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
[TBL] [Abstract][Full Text] [Related]
10. In vitro synthesis of IgM rheumatoid factor by lymphocytes from patients with essential mixed cryoglobulinemia.
Meroni PL; Barcellini W; Sinico RA; Fornasieri A; Sguotti C; Invernizzi F; D'Amico G; Zanussi C
Clin Exp Immunol; 1986 Aug; 65(2):303-10. PubMed ID: 3491708
[TBL] [Abstract][Full Text] [Related]
11. Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor.
Roudier J; Silverman GJ; Chen PP; Carson DA; Kipps TJ
J Immunol; 1990 Feb; 144(4):1526-30. PubMed ID: 1689356
[TBL] [Abstract][Full Text] [Related]
12. In vitro immunoglobulin production by lymphocytes of patients with juvenile rheumatoid arthritis: effects of Staphylococcus aureus Cowan I stimulation and monocyte depletion.
Oen K; Krzekotowska D
J Rheumatol; 1988 Oct; 15(10):1539-46. PubMed ID: 3264580
[TBL] [Abstract][Full Text] [Related]
13. T cell regulation of in vitro IgM-rheumatoid factor production by normal human B cells. Differential effects of stimulation with immobilized monoclonal antibodies to CD3 and Staphylococcus aureus.
Hirohata S; Inoue T; Miyamoto T
Arerugi; 1990 Feb; 39(2 Pt 1):82-9. PubMed ID: 2141251
[TBL] [Abstract][Full Text] [Related]
14. In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults.
Koopman WJ; Schrohenloher RE
J Immunol; 1980 Aug; 125(2):934-9. PubMed ID: 6967092
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin-mediated immunoregulation: reduced sensitivity of in vitro immunoglobulin production to indomethacin in rheumatoid arthritis.
Staite ND; Ganczakowski M; Panayi GS; Unger A
Clin Exp Immunol; 1983 Mar; 51(3):535-42. PubMed ID: 6602019
[TBL] [Abstract][Full Text] [Related]
16. Cell surface antigen CD5 is a marker for activated human B cells.
Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
[TBL] [Abstract][Full Text] [Related]
17. IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.
Hidaka T; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishizuka T; Kawagoe M; Nakamura H
Clin Exp Immunol; 1992 Aug; 89(2):223-9. PubMed ID: 1379131
[TBL] [Abstract][Full Text] [Related]
18. Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen.
Suzuki N; Sakane T; Ueda Y; Murakawa Y; Tsunematsu T
J Clin Invest; 1986 Jan; 77(1):294-300. PubMed ID: 3484752
[TBL] [Abstract][Full Text] [Related]
19. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals.
Jasin HE
Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929
[TBL] [Abstract][Full Text] [Related]
20. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
Lorber M; Samuel D; Amlot P; Panayi GS
Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]